Skip to main content
. 2016 Feb 18;5(5):e1139662. doi: 10.1080/2162402X.2016.1139662

Figure 3.

Figure 3.

Impact of lenalidomide therapy on the CD4+CD127dimCD25high Foxp3+regulatory T-cell compartment. Shown is the percentage of CD4+CD127dimCD25highFoxp3+regulatory T cell of all CD4+ T cells in patients with MM treated with or without lenalidomide, analyzed by flow cytometry.